No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
AORT250117C30000
- 0.33
- +0.28+560.00%
15min DelayClose Dec 31 16:00 ET
0.33High0.33Low
0.33Open0.05Pre Close3 Volume49 Open Interest30.00Strike Price99.00Turnover33.74%IV6.09%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier16DDays to Expiry0.33Extrinsic Value100Contract SizeAmericanOptions Type0.2719Delta0.1616Gamma86.64Leverage Ratio-0.0217Theta0.0034Rho23.55Eff Leverage0.0202Vega
Intraday
- 5D
- Daily
News
Have Insiders Sold Artivion Shares Recently?
In-Depth Examination Of 6 Analyst Recommendations For Artivion
FDA Grants Humanitarian Device Exemption to Artivion's Aortic Arch Remodeling Device
JMP Securities Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $33
Artivion Analyst Ratings
Needham Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $34